Vimta Labs Limited (NSE:VIMTALABS)
505.40
+0.90 (0.18%)
Nov 11, 2026, 1:54 PM IST
Vimta Labs Revenue
Vimta Labs had revenue of 1.12B INR in the quarter ending September 30, 2026, with 9.95% growth. This brings the company's total for the last twelve months to 4.31B, up 11.98% year-over-year. In the fiscal year ending March 31, 2026, Vimta Labs had annual revenue of 4.10B with 18.62% growth.
Revenue (ttm)
4.31B
Revenue Growth
+11.98%
P/S Ratio
5.23
Revenue / Employee
3.12M
Employees
1,384
Market Cap
22.54B
Revenue by Geography
- India 2.54B 62.5%
- Foreign 1.53B 37.5%
Fiscal year ended Mar 31, 2026 See the full Vimta Labs breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.10B | 643.01M | 18.62% |
| Mar 31, 2025 | 3.45B | 557.57M | 19.25% |
| Mar 31, 2024 | 2.90B | -294.23M | -9.22% |
| Mar 31, 2023 | 3.19B | 402.99M | 14.46% |
| Mar 31, 2022 | 2.79B | 677.23M | 32.09% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Laurus Labs | 78.23B |
| Dishman Carbogen Amcis | 29.01B |
| Indoco Remedies | 19.09B |
| Windlas Biotech | 9.93B |
| Medi Assist Healthcare Services | 9.60B |
Vimta Labs News
- 11 days ago - Vimta Labs Transcript: Q2 26/27 - Transcripts
- 11 days ago - Vimta Labs Quarterly report: Q2 2027 - Filings
- 11 days ago - Vimta Labs Slides: Q2 2027 - Filings
- 3 months ago - Vimta Labs Transcript: Q1 26/27 - Transcripts
- 3 months ago - Vimta Labs Quarterly report: Q1 2027 - Filings
- 3 months ago - Vimta Labs Slides: Q1 2027 - Filings
- 4 months ago - Vimta Labs pays Rs 2 dividend per share for FY 2025-26 - Business Upturn
- 5 months ago - Vimta Labs Transcript: Q4 25/26 - Transcripts